• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Retractable Technologies Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    6/6/25 3:56:47 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care
    Get the next $RVP alert in real time by email
    false 0000946563 0000946563 2025-06-02 2025-06-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported) June 2, 2025

     

    Retractable Technologies, Inc.

    (Exact name of registrant as specified in its charter)

     

    Texas 001-16465 75-2599762
    (State or other jurisdiction (Commission (IRS Employer
    of incorporation) File Number) Identification No.)

     

    511 Lobo Lane, Little Elm, Texas 75068-5295
    (Address of principal executive offices) (Zip Code)

     

    Registrant's telephone number, including area code (972) 294-1010

     

    None

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbol(s) Name of each exchange on which registered
    Common Stock RVP NYSE American

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

      Emerging growth company  ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

     

     

     

     

     

    Item 4.01Changes in Registrant’s Certifying Accountant.

     

    On June 2, 2025, Retractable Technologies Inc. (the “Company”) was notified that Moss Adams LLP (“Moss Adams”), the Company’s independent registered public accounting firm, merged with Baker Tilly US, LLP effective on June 3, 2025. The combined audit practices operate as Baker Tilly US, LLP (“Baker Tilly”). In connection with the notification of the merger, Moss Adams has resigned as the auditors of the Company and the Audit Committee of the Company’s Board of Directors approved the appointment of Baker Tilly, as the successor to Moss Adams, as the Company’s independent registered public accounting firm.

     

    The audit reports of Moss Adams on the Company’s consolidated financial statements for the years ended December 31, 2024 and 2023, and for each of the three-years in the period ended December 31, 2024, did not contain an adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles.

     

    During the years ended December 31, 2024 and 2023, and the subsequent interim period through June 2, 2025, there were no (a) disagreements with Moss Adams on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to Moss Adams’ satisfaction, would have caused it to make reference to the subject matter of the disagreement in connection with its reports on the Company’s financial statements, or (b) reportable events requiring disclosure pursuant to Item 304(a)(1)(v) of Regulation S-K.

     

    During the years ended December 31, 2024 and 2023, and the subsequent interim period through the date of this Current Report on Form 8-K, neither the Company, nor anyone on its behalf, consulted with Baker Tilly regarding: (i) either the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements; or (ii) any matter that was either the subject of a “disagreement,” as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions to that item, or a “reportable event,” as described in Item 304(a)(1)(v) of Regulation S-K.

     

    The Company provided Moss Adams with a copy of this Current Report on Form 8-K prior to its filing with the Securities and Exchange Commission (the “Commission”) and requested that Moss Adams furnish the Company with a letter addressed to the Commission stating whether it agrees with the above statements and, if it does not agree, the respects in which it does not agree. A copy of Moss Adams’ letter to the Commission, dated June 6, 2025, is filed as Exhibit 16 to this Form 8-K and is incorporated herein by reference.

     

    Item 9.01Financial Statements and Exhibits.

     

    (d)  Exhibits

     

    16Letter dated June 6, 2025 pursuant to Item 304(a) of Regulation S-K.

     

    104Cover Page Interactive Date File (embedded within the Inline XBRL document)

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    DATE:  June 6, 2025 RETRACTABLE TECHNOLOGIES, INC.
      (Registrant)
         
      BY:  /s/ JOHN W. FORT III
        JOHN W. FORT III
        VICE PRESIDENT, CHIEF FINANCIAL OFFICER, AND CHIEF ACCOUNTING OFFICER

     

     

     

    Get the next $RVP alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RVP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $RVP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Retractable Technologies, Inc. Results for the Periods Ended June 30, 2025

    Retractable Technologies, Inc. (NYSE:RVP) reports total net sales of $10.4 million for the second quarter of 2025 and an operating loss of $5.1 million for the period, as compared to total net sales for the same period last year of $6.0 million and an operating loss of $5.8 million. For the first half of the year, net sales were $18.7 million and operating losses were $9.8 million as compared to 2024 net revenues of $13.6 million and operating losses of $8.7 million. Increased EasyPoint® needle sales in the first six months of 2025 positively affected overall net revenues, but the lower selling price attributable to the products resulted in a reduction of the total average selling price for

    8/14/25 4:50:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    Retractable Technologies, Inc. Announces Reduction in Its Manufacturing Workforce

    Retractable Technologies, Inc. (NYSE:RVP) reports that it has reduced its workforce by approximately 12.4%. The reduction is expected to save an estimated $1.6 million in annual wages and benefits, or approximately 8.6% of total estimated workforce costs. The expected savings is offset by one-time separation payments of approximately $56 thousand to the affected workers. The reduction targets the Company's manufacturing and manufacturing support positions as the Company continues to balance its domestic manufacturing presence against its reliance on imported products and associated tariffs from its Chinese contract manufacturers. While contract manufacturers in China have historically pro

    7/23/25 4:50:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

    Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning April 1, 2025 through June 30, 2025. The dividends will be paid on July 21, 2025 to shareholders of record as of the close of business on July 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter

    6/30/25 2:04:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $RVP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT AND CEO Shaw Thomas J bought $2,346 worth of shares (3,000 units at $0.78), increasing direct ownership by 0.02% to 15,653,825 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    9/4/25 11:08:15 AM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    PRESIDENT AND CEO Shaw Thomas J bought $4,416 worth of shares (5,500 units at $0.80), increasing direct ownership by 0.04% to 15,650,825 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    9/3/25 11:15:06 AM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    PRESIDENT AND CEO Shaw Thomas J bought $7,200 worth of shares (9,042 units at $0.80), increasing direct ownership by 0.06% to 15,645,325 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    8/20/25 11:02:56 AM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $RVP
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Retractable Technologies Inc.

    SCHEDULE 13D/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)

    8/29/25 3:58:22 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    Retractable Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)

    8/14/25 5:08:55 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Retractable Technologies Inc.

    10-Q - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)

    8/14/25 2:57:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $RVP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT AND CEO Shaw Thomas J bought $2,346 worth of shares (3,000 units at $0.78), increasing direct ownership by 0.02% to 15,653,825 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    9/4/25 11:08:15 AM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    PRESIDENT AND CEO Shaw Thomas J bought $4,416 worth of shares (5,500 units at $0.80), increasing direct ownership by 0.04% to 15,650,825 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    9/3/25 11:15:06 AM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    PRESIDENT AND CEO Shaw Thomas J bought $7,200 worth of shares (9,042 units at $0.80), increasing direct ownership by 0.06% to 15,645,325 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    8/20/25 11:02:56 AM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $RVP
    Leadership Updates

    Live Leadership Updates

    View All

    Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Convertible Preferred Stock Shareholders

    LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $10,041 and $39,050, respectively. Over the entire accrual period, the dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders. Dividends have accrued at 10% per annum and cover amounts in arrears from October 1, 2020 through date of conversion or December 31, 2020 whichever is applicable. The dividends will be paid on January 29, 2021. All Series I Class B Conv

    1/8/21 2:32:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $RVP
    Financials

    Live finance-specific insights

    View All

    Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

    Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning April 1, 2025 through June 30, 2025. The dividends will be paid on July 21, 2025 to shareholders of record as of the close of business on July 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter

    6/30/25 2:04:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

    Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2025 through March 31, 2025. The dividends will be paid on April 21, 2025 to shareholders of record as of the close of business on April 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV cathe

    3/28/25 4:53:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

    Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning October 1, 2024 through December 31, 2024. The dividends will be paid on January 20, 2025 to shareholders of record as of the close of business on January 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and

    12/30/24 12:59:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $RVP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Retractable Technologies Inc. (Amendment)

    SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)

    2/8/23 2:38:31 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Retractable Technologies Inc. (Amendment)

    SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)

    5/2/22 4:33:55 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Retractable Technologies Inc. (Amendment)

    SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)

    1/27/22 2:27:52 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care